Related Experiment Videos
Computed tomography of Wilson disease
AJNR. American Journal of Neuroradiology
|May 1, 1983
Summary
Computed tomography (CT) scans revealed brain abnormalities in patients with Wilson disease (hepatolenticular degeneration). While some patients showed normal CT results, others exhibited atrophy and hypodense lesions, indicating potential neurological involvement.
Area of Science:
- Neurology
- Radiology
- Hepatology
Background:
- Wilson disease (hepatolenticular degeneration) is a genetic disorder causing copper accumulation.
- Neurological and hepatic manifestations are common in Wilson disease.
- Computed tomography (CT) is a valuable imaging tool for assessing brain structure.
Purpose of the Study:
- To evaluate the utility of CT in detecting brain abnormalities in patients diagnosed with Wilson disease.
- To correlate CT findings with the clinical presentation of Wilson disease.
Main Methods:
- Computed tomography (CT) scans were performed on 25 patients with biochemically confirmed Wilson disease.
- CT findings were analyzed for atrophy, hypodense lesions, and other structural changes.
- Clinical presentation (hepatic vs. neurological) was considered in relation to CT results.
Main Results:
- CT scans were normal in 7 out of 25 patients; 5 of these had the hepatic form of Wilson disease.
- Mild CT abnormalities, including basal ganglia and cerebellar atrophy, were observed in 10 patients.
- Severe CT abnormalities, such as subcortical and brainstem atrophy with hypodense lesions, were found in 8 patients.
- Hypodense lesions in the lentiform and dentate nuclei were noted, but quantitative analysis did not show significant differences from normal values.
Conclusions:
- CT imaging can reveal brain structural changes in Wilson disease, even in clinically asymptomatic or primarily hepatic forms.
- The severity of CT abnormalities appears to correlate with the neurological involvement in Wilson disease.
- While visual assessment detects lesions, quantitative CT analysis may require further refinement for subtle changes in Wilson disease.